Miyamoto S, Suzuki T. Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development. Vaccine 2024 Feb 2:S0264-410X(24)00112-9. doi: 10.1016/j.vaccine.2024.
PMID: 38310015